ZAI LAB LTD-ADR (ZLAB:NASDAQ)
$24.99 0.18 (0.7255%)
Analysed ZAI LAB LTD-ADR (ZLAB:NASDAQ) News Sources
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
09-10-2026
fool.com
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 2% for Week
28-08-2026
yahoo.com
Big Pharma Is Pouring Billions Into China’s Biotechs
14-09-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
08-10-2026
yahoo.com
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18-08-2026
yahoo.com
Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics
20-08-2026
yahoo.com
Zai Lab (ZLAB) Stock Looks Stretched On Sales But Reasonable On Broader Checks
06-09-2026
yahoo.com
Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
29-09-2026
yahoo.com
Is Zai Lab (ZLAB) Cheap After Its ESMO 2026 Lung Cancer Data Update?
04-10-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
06-10-2026
yahoo.com
What is the current price of ZAI LAB LTD-ADR (ZLAB:NASDAQ)?
The current price of ZAI LAB LTD-ADR (ZLAB:NASDAQ) is $24.99.
ZAI LAB LTD-ADR (ZLAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZAI LAB LTD-ADR (ZLAB:NASDAQ) since the previous trading day is $0.18.
ZAI LAB LTD-ADR (ZLAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZAI LAB LTD-ADR (ZLAB:NASDAQ) since the previous trading day is 0.7255%.
What is the most recent average sentiment score for ZAI LAB LTD-ADR (ZLAB:NASDAQ)?
The most recent average sentiment score for ZAI LAB LTD-ADR (ZLAB:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for ZAI LAB LTD-ADR (ZLAB:NASDAQ)?
The most recent sentiment for ZAI LAB LTD-ADR (ZLAB:NASDAQ) is .
SEC-8K** Filing Available For ZAI LAB LTD-ADR (ZLAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.